FIBROSIS, LIVER
Clinical trials for FIBROSIS, LIVER explained in plain language.
Never miss a new study
Get alerted when new FIBROSIS, LIVER trials appear
Sign up with your email to follow new studies for FIBROSIS, LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes pill stop liver damage in hepatitis b?
Disease control OngoingThis study tests whether empagliflozin, a diabetes drug, can prevent liver scarring (fibrosis) from getting worse in people with chronic hepatitis B. About 106 adults with moderate to severe liver scarring will take either the drug or a placebo daily for three years. The goal is …
Matched conditions: FIBROSIS, LIVER
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Can a custom coaching program slow liver damage?
Knowledge-focused OngoingThis study tests whether a personalized, behavior-based program can help people with early signs of liver disease (fatty liver or scarring) manage their condition better than standard care. About 49 adults with risk factors like obesity or diabetes will take part. The goal is to …
Matched conditions: FIBROSIS, LIVER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Hidden liver risk in type 1 diabetes revealed by new study
Knowledge-focused OngoingThis study looks at how often people with type 1 diabetes have nonalcoholic fatty liver disease (NAFLD) and serious liver scarring. Researchers used a painless ultrasound-like test and blood scores to check 533 adults at a diabetes clinic. The goal is to find high-risk patients w…
Matched conditions: FIBROSIS, LIVER
Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC